Menuju konten utama

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to sh

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
PR Newswire Asia - Tirto EN
Jadikan tirto.id sumber pilihan pencarian Google

ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).

By the end of the reporting period, INTCO Medical's annualized production capacity for disposable gloves had reached 107 billion pieces. The total comprised 74 billion disposable nitrile gloves and 33 billion disposable vinyl gloves. This scale reinforces the Company's position as the world's largest producer of disposable gloves.

INTCO Medical's integrated value chain extends from nitrile latex and the research, development and manufacturing of core production equipment to glove production and global sales. Through nitrile latex manufacturers in which it holds controlling or equity interests, the Company strengthens raw material supply security, helping mitigate the impact of international crude oil price fluctuations on key raw material costs while enhancing supply stability and cost efficiency. Its coordinated domestic and international production capacity enables the Company to allocate manufacturing resources according to market demand, respond efficiently to customer needs and support reliable delivery across global markets. Together, these capabilities strengthen operational resilience.

During the reporting period, R&D expenses rose 20.62% to RMB 245.9 million (approx. US$36.6 million). The Company continued to develop high-performance products, including Syntex™ Synthetic Latex Gloves, a proprietary glove that does not contain natural latex proteins and offers high elasticity and puncture resistance, and Synmax Pro Exam Gloves, an enhanced vinyl glove for food service and industrial applications. The Company has also introduced safety work gloves, household gloves and other products to meet diverse application needs.

Smart manufacturing boosts efficiency and quality. INTCO Medical's latest nitrile glove production line spans more than 1.6 kilometers and incorporates about 500 control points. Its precision distributed control system automatically manages temperature and liquid levels based on production conditions, helping reduce labor and energy consumption while maintaining stable output. The Company's glove product yield remained above 99% during the reporting period.

INTCO Medical will continue optimizing global capacity and advancing protective product innovation to support growth.

Sumber: www.prnasia.com

Disclaimer: This press release was supplied by a third party. Tirto is not involved in its preparation and bears no responsibility for its content.

Reporter: PR Newswire
Penulis: PR Newswire
Editor: PR Newswire